Minerva Surgical, Inc. (UTRS)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

At close: Jan 29, 2026

9,900% (1Y)

Market Cap	888.00
Revenue (ttm)	51.69M
Net Income (ttm)	-33.45M
Shares Out	8.88M
EPS (ttm)	-5.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	110
Average Volume	1,120
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	81.92
RSI	19.72
Earnings Date	Mar 20, 2026

About Minerva Surgical

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities. It also offers Resectr, a tissue resection device to diagnose and treat polyps... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2008

Employees 174

Stock Exchange OTCMKTS

Ticker Symbol UTRS

Full Company Profile

Financial Performance

In 2022, Minerva Surgical's revenue was $50.29 million, a decrease of -3.47% compared to the previous year's $52.10 million. Losses were -$34.11 million, 58.9% more than in 2021.

Financial Statements

News

There is no news available yet.